obidoxime chloride has been researched along with Central Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appu, AP; Arun, P; Baskota, S; Braga, MFM; Dagata, J; Farkas, N; Figueiredo, TH; Frey, WH; Krishnan, JKS; Moffett, JR; Namboodiri, AMA; Olsen, CH; Vijayakumar, N | 1 |
| Gralewicz, S | 1 |
1 review(s) available for obidoxime chloride and Central Nervous System Diseases
| Article | Year |
|---|---|
[Possible consequences of acetylcholinesterase inhibition in organophosphate poisoning. Discussion continued].
Topics: Acetylcholinesterase; Central Nervous System Diseases; Cognition; Cognition Disorders; Humans; Insecticides; Obidoxime Chloride; Organophosphate Poisoning | 2006 |
1 other study(ies) available for obidoxime chloride and Central Nervous System Diseases
| Article | Year |
|---|---|
Intranasal delivery of obidoxime to the brain prevents mortality and CNS damage from organophosphate poisoning.
Topics: Acetylcholinesterase; Administration, Intranasal; Animals; Biological Availability; Brain; Central Nervous System Diseases; Cholinesterase Reactivators; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Male; Obidoxime Chloride; Organophosphate Poisoning; Pralidoxime Compounds; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tritium | 2016 |